Pacira BioSciences, Inc. (PCRX) Insider Ownership

Historic Ownership Trends

Through the 90-day period concluding January 02, 2026, Pacira BioSciences's top three insider stakeholders include Chief Medical Officer Jonathan Slonin (178.37K shares), Chief Financial Officer Shawn Cross (56.25K shares), Director Marcelo Bigal (11.39K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Andreas Wicki 451,324 16 Mar, 2021
Frank D. Lee Chief Executive Officer 448,409 04 Feb, 2025
David M Stack Ceo And Chairman 283,754 16 Jun, 2023
Jonathan Slonin Chief Medical Officer 178,367 19 Nov, 2025
Kristen Williams Chief Administrative Officer 161,574 05 Jun, 2025
Daryl Gaugler Chief Operating Officer 115,443 06 Jan, 2025
Lauren Riker Senior Vice President And Finance 59,564 05 Jun, 2025
Shawn Cross Chief Financial Officer 56,250 11 Dec, 2025
Brendan Teehan Chief Commercial Officer 54,000 04 Feb, 2025
Roy Winston Chief Medical Officer 52,440 04 Aug, 2023
Charles A. Iii Reinhart Chief Financial Officer 51,867 13 Jun, 2024
Charles Anthony Laranjeira Chief Technical Officer 41,752 16 Jun, 2022
Dennis Mcloughlin Chief Customer Officer 38,115 07 Jun, 2023
Mark A. Kronenfeld 34,901 13 Jun, 2025
Ronald J. Jr. Ellis Chief Strategy Officer 30,909 07 Jun, 2023
Donald C. Manning Chief Medical Officer 29,520 11 Jun, 2021
Max Reinhardt President And Rest Of World 29,225 07 Jun, 2023
Laura Brege 23,715 13 Jun, 2025
Gary W Pace 22,127 08 Mar, 2024
Mark Froimson 20,636 13 Jun, 2025
John P Phd Longenecker 18,823 07 Mar, 2022
Christopher Christie 16,654 13 Jun, 2025
Michael J. Yang 13,393 13 Jun, 2025
Yvonne Greenstreet 13,247 08 Jun, 2022
Anthony Molloy Chief Lgl & Compliance Officer 12,877 07 Jun, 2023
Paul J Hastings 12,724 13 Jun, 2024
Marcelo Bigal 11,393 11 Aug, 2025
Alethia Young 11,393 13 Jun, 2025
Abraham Ceesay 9,039 08 Sep, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
09 Dec, 2025 Shawn Cross Common Stock A 15,896 $16.45 72,146 D M
09 Dec, 2025 Shawn Cross Common Stock D 15,896 $25.03 56,250 D S
10 Dec, 2025 Shawn Cross Common Stock A 9,104 $16.45 65,354 D M
10 Dec, 2025 Shawn Cross Common Stock D 9,104 $25.14 56,250 D S
17 Nov, 2025 Jonathan Slonin Common Stock D 3,960 $24.09 178,367 D S
10 Nov, 2025 Shawn Cross Common Stock D 12,060 $22.09 56,250 D S
31 Oct, 2025 Shawn Cross Common Stock D 6,690 $21.38 68,310 D F
04 Sep, 2025 Abraham Ceesay - - 9,039 D
04 Sep, 2025 Abraham Ceesay Common Stock D 2,354 $27.19 9,039 D S
07 Aug, 2025 Marcelo Bigal - - 11,393 D
07 Aug, 2025 Marcelo Bigal Common Stock D 4,912 $23.67 11,393 D S
01 Aug, 2025 Jonathan Slonin Common Stock D 315 $22.07 182,327 D F
11 Jun, 2025 Mark Froimson Common Stock A 6,163 $0.00 20,636 D A
11 Jun, 2025 Laura Brege - - 23,715 D
11 Jun, 2025 Michael J. Yang Common Stock A 6,163 $0.00 13,393 D A
11 Jun, 2025 Mark A. Kronenfeld Common Stock A 9,999 $0.00 34,901 D A
11 Jun, 2025 Marcelo Bigal Common Stock A 6,163 $0.00 16,305 D A
11 Jun, 2025 Alethia Young Common Stock A 6,163 $0.00 11,393 D A
11 Jun, 2025 Abraham Ceesay Common Stock A 6,163 $0.00 11,393 D A
11 Jun, 2025 Christopher Christie Common Stock A 6,163 $0.00 16,654 D A